Filing summary
BioRestorative Therapies, Inc. (Nasdaq: BRTX) filed this Form 8-K regarding a board appointment effective October 7, 2026. The report was signed October 9, 2026.
Business context and financial information
The filing reports a corporate governance change, not financial results. It provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics, and no comparable-period figures.
Board change and compensation
- The board appointed Donald J. Currie as a Class I director, filling the vacancy resulting from Katharyn Field’s resignation effective August 31, 2026. Currie is to serve until the 2027 annual meeting and until a successor is elected and qualified, unless his service ends earlier.
- Currie was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee. The filing lists the membership of all three standing committees.
- The board determined that Currie is independent under applicable Nasdaq and SEC standards.
- Currie will receive CAD $2,000 per month, payable monthly in arrears, plus reimbursement of reasonable out-of-pocket expenses. He will not participate in the company’s standard non-employee director compensation program.
- The company expects to enter into an indemnification agreement with Currie in the form previously filed on September 2, 2026.
Management commentary, risks, and unusual items
The filing describes Currie’s experience as CEO and director of Hillcrest Energy Technologies Ltd. and his background in energy, public-company financing, corporate strategy, and capital raising. It reports no appointment arrangement, family relationship with company directors or executive officers, or reportable related-party transaction involving Currie. No guidance, financial outlook, or new business risks are provided.
Important facts to verify
- Confirm Currie’s appointment, committee assignments, and term in subsequent company disclosures.
- Check whether the expected indemnification agreement was executed and filed.
- Review future filings for updates to board composition and director compensation.